EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma

Boyang Li, Shihui Liu, Xiaowan Zhou, Dongpu Hou, Huajie Jia, Rude Tang, Yunqing Zhang, Mengqiu Song iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Boyang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Apoptosis, Tumor Suppressor Protein p53, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Science and Technology Research Project, Postdoctoral Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with a poor prognosis and limited effective treatment options. This study investigates the therapeutic potential of Deferasirox (DFO), an iron chelator, in ESCC by targeting TAOK1, an STE20-type kinase implicated in cancer development. We demonstrate that DFO significantly inhibits the proliferation and colony formation of ESCC cells in a dose- and time-dependent manner. Mechanistic investigations reveal that DFO binds directly to TAOK1 and reduces its kinase activity. Proteomics and phosphorylated proteomic sequencing analysis further reveal that TAOK1 knocking down dramatically increased p53-mediated apoptosis. Moreover, the inhibition of TAOK1 by DFO or lenti-virus infection induces apoptosis in ESCC cells, as evidenced by the increased expression of p53, p-p53 (S15), p-p53 (S46), Puma, Noxa, and Bax, and the decreased expression of Bcl-2. Furthermore, in vivo studies using patient-derived xenograft (PDX) mouse models show that DFO treatment significantly reduces tumor volume without observable toxicity. Histological and immunohistochemical analyses confirm the down-regulation of TAOK1 and Ki-67, and the up-regulation of p53 expression in DFO-treated tumors. Our findings suggest that DFO exerts its antitumor effects in ESCC by targeting TAOK1, providing a potential therapeutic strategy for ESCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisTumor Suppressor Protein p53Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsDeferasiroxProtein Serine-Threonine KinasesHumansAnimalsCell Line, TumorMiceCell ProliferationXenograft Model Antitumor AssaysGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

TAOK1apoptosisdeferasiroxesophageal squamous cell carcinomatargeted therapy

Substanzen

Tumor Suppressor Protein p53DeferasiroxProtein Serine-Threonine KinasesTP53 protein, human

Autor:innen und Institutionen

  • Department of Pathophysiology, School of Basic Medical Sciences, College of Medicine, Zhengzhou University, Zhengzhou 450001, China.
  • The First Clinical School of Medicine, Zhengzhou University, Zhengzhou 450001, China.
  • China-US (Henan) Hormel Cancer Institute, No. 127, Dongming Road, Jinshui District, Zhengzhou 450008, China.
  • Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Henan International Joint Laboratory of Cancer Chemoprevention, Zhengzhou University, Zhengzhou 450001, China.
  • State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou 450001, China.

ORCID-Profile: Mengqiu Song

Förderung

  • Henan Provincial Science and Technology Research Project
  • Postdoctoral Science Foundation of China

Zitieren

APA

Li, B., Liu, S., Zhou, X., Hou, D., Jia, H., Tang, R., Zhang, Y., & Song, M. (2025). Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041524

Vancouver

Li B, Liu S, Zhou X, Hou D, Jia H, Tang R, et al. Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041524

BibTeX
@article{Li2025,
  author = {Li, Boyang and Liu, Shihui and Zhou, Xiaowan and Hou, Dongpu and Jia, Huajie and Tang, Rude and Zhang, Yunqing and Song, Mengqiu},
  title = {Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041524}
}
Kostenlos starten →